Clinical Trial Update: Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of methotrexate, trimetrexate glucuronate, and leucovorin in patients with refractory or recurrent osteosarcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Leucovorin (folinic acid)
• METHOTREXATE (METHOTREXATE)
• Trimetrexate Glucuronate (trimetrexate glucuronate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 1 | Status: COMPLETED